Concepedia

Author

Laura Aschenbrenner

Pfizer (United States)

Also Known As

L Aschenbrenner, Laura Aschenbrenner, Laura M. Aschenbrenner, Laura M. Aschenbrenner

38

Publications

792

Citations

10

H-Index

16

Concepts

All Affiliations

Pfizer (United States)Covance (United States)Nexogen (United States)Allogene Therapeutics (United States)Bristol-Myers Squibb (Germany)
LA

About

Laura Aschenbrenner is an author at Pfizer (United States) specializing in molecular biology, pathogenesis, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

157

2

Natural Sciences

2

2

37

3

Immunology

2

2

157

4

Biochemistry

1

1

20

5

Chemical Biology

1

1

20

Laura Aschenbrenner

×

10

Publications

779

Citations

10

H-Index

YearCitations

Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus Infection

Michael P. Malakhov, Laura Aschenbrenner, Donald F. Smee,

Antimicrobial Agents and Chemotherapy

2006

231

DAS181, A Novel Sialidase Fusion Protein, Protects Mice from Lethal Avian Influenza H5N1 Virus Infection

Jessica A. Belser, Xiuhua Lu, Kristy J. Szretter,

The Journal of Infectious Diseases

2007

140

RN927C, a Site-Specific Trop-2 Antibody–Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models

Pavel Strop, Thomas-Toan Tran, Magdalena Dorywalska,

Molecular Cancer Therapeutics

2016

98

Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer

Guoyun Zhu, Davide Foletti, Xiaohui Liu,

Scientific Reports

2019

70

DAS181, a sialidase fusion protein, protects human airway epithelium against influenza virus infection: an in vitro pharmacodynamic analysis

Gallen Triana‐Baltzer, Maria Babizki, Michael C. W. Chan,

Journal of Antimicrobial Chemotherapy

2009

64

Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181

Gallen Triana‐Baltzer, Rebecca Sanders, Maria Hedlund,

Journal of Antimicrobial Chemotherapy

2010

51

Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma

Siler H. Panowski, Tracy C. Kuo, Yi Zhang,

Molecular Cancer Therapeutics

2019

45

Sialidase‐Based Anti–Influenza Virus Therapy Protects against Secondary Pneumococcal Infection

Maria Hedlund, Laura Aschenbrenner, Kellie Jensen,

The Journal of Infectious Diseases

2010

43

Calcium Ion Downregulates Soluble Guanylyl Cyclase Activity: Evidence for a Two-metal Ion Catalytic Mechanism

Lucile Serfass, Heather S. Carr, Laura Aschenbrenner,

Archives of Biochemistry and Biophysics

2001

20

A Safety Evaluation of DAS181, a Sialidase Fusion Protein, in Rodents

Jeffrey L. Larson, Seong-Kwi Kang, Bo In Choi,

Toxicological Sciences

2011

17

Page 1